The prediction of cancer recurrence using serum level of CA 19-9 in patients with curative operation of pancreatic cancer in the CONKO 001 cohort

被引：0
|
作者：
Pelzer, U.
Bahra, M. [2 ]
Viol, R. M.
Sinn, M.
Stieler, J. M.
Gebauer, B. [3 ]
Doerken, B.
Oettle, H. [1 ]
Neuhaus, P. [2 ]
Riess, H.
机构：
[1] Charite, Ctr Tumormed, Outpatient Dept Friedrichshafen, D-13353 Berlin, Germany
[2] Charite, Klin Allgemein Visceral & Transplantat Chirurg, D-13353 Berlin, Germany
[3] Charite, Inst Radiol, Abt Neuroradiol & Kinderradiol CCM CVK, D-13353 Berlin, Germany
来源：
ONKOLOGIE | 2012年 / 35卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：161 / 161
页数：1
相关论文
共 50 条
  • [21] Utility of serum CA 19-9 monitoring in preoperative radiotherapy for pancreatic cancer
    Ohara, K
    Tatsuzaki, H
    Molotkova, NG
    Oda, T
    Yuzawa, K
    Saida, Y
    Matsuzaki, Y
    Shimizu, W
    Todoroki, T
    Fukao, K
    Tanaka, N
    Itai, Y
    HEPATO-GASTROENTEROLOGY, 2001, 48 (39) : 859 - 863
  • [22] The role of Ca 19-9 in progression, recurrence and survival of borderline resectable pancreatic cancer
    Almeida, C.
    Goncalves, M.
    Freitas, M.
    Teixeira, C.
    Couto, M.
    Lemos, T.
    Meireles, S.
    Rego, I.
    Sarmento, C.
    Coelho, A.
    Costa, A.
    Barbosa, M.
    ANNALS OF ONCOLOGY, 2023, 34 : S143 - S144
  • [23] CA 19-9: Not a magic marker for pancreatic cancer
    Daram, Sumanth R.
    SOUTHERN MEDICAL JOURNAL, 2006, 99 (03) : 205 - 205
  • [24] Exploiting the relevance of CA 19-9 in pancreatic cancer
    Salleh, Syaza
    Thyagarajan, Anita
    Sahu, Ravi P.
    JOURNAL OF CANCER METASTASIS AND TREATMENT, 2020, 6
  • [25] Is CA 19-9 useful in the management of pancreatic cancer?
    Balzano, Gianpaolo
    Di Carlo, Valerio
    LANCET ONCOLOGY, 2008, 9 (02): : 89 - 91
  • [26] CA 19-9 and Lewis Antigens in Pancreatic Cancer
    Atkins, Carl D.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15) : 2572 - 2573
  • [27] The use of adjusted preoperative CA 19-9 to predict the recurrence of resectable pancreatic cancer
    Kang, Chang Moo
    Kim, Jun Young
    Choi, Gi Hong
    Kim, Kyung Sik
    Choi, Jin Sub
    Lee, Woo Jung
    Kim, Byong Ro
    JOURNAL OF SURGICAL RESEARCH, 2007, 140 (01) : 31 - 35
  • [28] Correlation Analysis of Baseline Serum CA 19-9, CEA, and CA 125 in Patients With Advanced Pancreatic Cancer
    Deng, G.
    Yan, H.
    Guo, Z.
    Dai, G.
    PANCREAS, 2020, 49 (10) : 1406 - 1406
  • [29] SERUM AND PANCREATIC-JUICE CA 19-9 DETERMINATION IN PANCREATIC-CANCER DIAGNOSIS
    TOMMASINI, MA
    BOCCHIA, P
    MARCHI, R
    DICARLO, V
    BERETTA, E
    BERSANI, M
    MALESCI, A
    ITALIAN JOURNAL OF GASTROENTEROLOGY, 1985, 17 (03): : 171 - 172
  • [30] Clinical Significance of the Preoperative Serum CA 19-9 Level in Gastric Cancer
    Choi, A. Ra
    Park, Jun Chul
    Shin, Sung Kwan
    Lee, Sang Kil
    Lee, Yong Chan
    Chung, Jae Bock
    GASTROENTEROLOGY, 2012, 142 (05) : S632 - S632
12345